Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cervarix vs Gardasil Immune Response in Adolescent Girls
NCT00956553Phase 4Completed
- Sponsor
- UK Health Security Agency
- Start
- Sep 2009
- Primary completion
- Sep 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of human papillomavirus type 16 L1 capsid protein antigen, qHPV vaccine in human papillomavirus infection, sponsored by UK Health Security Agency. Started Sep 2009; status: completed.
02
Drugs
human papillomavirus type 16 L1 capsid protein antigenqHPV vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT00956553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00956553.